The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
he talked about even the use of ibogaine and MDMA, even in some younger populations but again, with therapeutic oversight. It blew my mind. I also didn't know this-- that MDMA I thought was toxic. Please don't just take it off the street, but if you're interested in clinical trials, there are great clinical trials happening through maps, and you can look at Nolan's website as well.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
however there are ways to use MDMA therapeutically that avoid avoid its toxicity and yet there are still questions about its toxicity and its long-term effects both after acute use meaning just one to three times as well as chronic use meaning people who have taken it many many times